 Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions Promising therapeutic developments for HIV, Parkinsons disease, Crohns disease, alopecia, multiple myeloma and breast cancer on horizon LONDON, Jan. 10, 2023 PRNewswire Clarivate Plc NYSE:CLVT, a global leader in providing trusted information and insights to accelerate the pace of innovation, today ... The post Clarivate Identifies Fifteen Potential Blockbuster Drugs... 